Vitamin treatment improves ED in men with elevated homocysteine
An article published online on August 17, 2009 in the Journal of Sexual Medicine describes research conducted at the University of Rome which found that it may be necessary to reduce homocysteine before treatment with erectile dysfunction (ED) can be effective.
The study included 75 men aged 25 to 65 with erectile dysfunction who were treated with sildenafil citrate (“Viagra”) for 2 months. Nonresponders to the drug were treated with a course of 600 milligrams vitamin B6 per week and 15 milligrams folic acid per day along with sildenafil for 6 weeks. Questionnaires concerning erectile function were administered before and after treatment.
Participants were evaluated for the presence of the MTHFR 677T mutation which is present in a higher percentage of heart disease patients than in those without the disease. Individuals with two copies of the mutation have levels of homocysteine that average 25 percent higher than the rest of the population, and which increase significantly when blood levels of folate are low. Twenty-seven percent of the subjects had both copies of the MTHFR 677T mutation and 48 percent had one copy, which is a greater frequency than the general populace.
All of the 18 patients who initially failed to respond to drug treatment had high levels of homocysteine and low folic acid levels. Subsequent to the 6 week course of vitamin therapy, folic acid levels increased, homocysteine concentrations declined, and all but two participants experienced improvement in ED.
The association of hyperhomocysteinemia with vascular disease supports the mechanism for homocysteine-reducing agents in improving ED, which is caused primarily by the same factors that affect the coronary arteries. “Measurement of plasma homocysteine and folic acid levels and molecular analysis of the MTHFR genotype should be added to the ED diagnostic procedure, especially in young patients or in those with a family history of cardiovascular disease," the authors conclude. "When this mechanism is implicated, treatment should first aim to reduce homocysteine levels through administration of folic acid, alone or in combination with vitamin B6 or B12, and then proceed to treatment with phosphodiesterase-5 inhibitors.”
Since the introduction of Viagra® (sildenafil citrate) in 1998, several other drugs for the treatment of ED have been introduced; it has become clear that ED is far more prevalent than may have been suspected previously. A study conducted in the Boston area from 1987 to 1989 found that 52 percent of men between the ages of 40 and 70 suffered some degree of ED (Feldman HA et al 1994). By extrapolation, about 30 million men are affected by ED in the United States (McKay D 2004). And given men’s ever increasing life span, it has been further estimated that the incidence of ED worldwide will more than double in the next quarter century (Goldstein I 2000).
Arginine is an amino acid the body uses to produce nitric oxide, which relaxes smooth muscle, thus allowing for increased blood flow in many parts of the body. This action may explain why ED is more common in men with forms of vascular disease in which disorders of nitric oxide play a role, such as ischemic heart disease and stroke. For example, 75 percent of men with ischemic heart disease suffer from ED (Kloner RA et al 2003).
Risk factors for ED include conditions such as high blood pressure, abnormally high blood lipids (i.e., elevated low-density lipoprotein cholesterol and triglycerides), obesity, diabetes, and smoking (McKay D 2004). Recently, some US scientists reported that it may be necessary to add aging itself to the list of risk factors that produce vascular dysfunction of the kind associated with ED. “The normal aging process may induce significant global vascular dysfunction (involving the endothelium and the vascular smooth muscle),” wrote scientists published in the International Journal of Cardiology. This age-associated dysfunction was judged to occur even in the absence of clinically diagnosed atherosclerosis and was related to alterations in the production of endothelial nitric oxide (Al-Shaer MH et al 2006).
The link between ED and vascular disease is so strong that physicians are advised to consider men who present with ED but no diagnosis of heart disease as undiagnosed cardiovascular patients until proven otherwise (Jackson G et al 2006). It is believed that alterations in the availability of vascular endothelial nitric oxide represent the common thread linking these interrelated pathologies (Sullivan ME et al 1999).
The Life Extension Foundation Buyers Club is celebrating its 21st Annual Super Sale! What does that mean for you? From now until February 1, 2010, you can purchase state-of-the-art dietary supplements at extra-discounted prices.
This year, we have more reasons to be excited about our Annual Super Sale. We are introducing over 40 new and reformulated products to help you maintain optimal health. Choose from vitamins, minerals, hormones, nutrition, weight loss and skin care products all backed by a 100% Satisfaction Guarantee†.
This Super Sale interactive page also features a better way to order multiple items! Simply select the items you would like to purchase and then scroll down to confirm your selection by clicking on the button that says Order Selected Items. It’s fast, easy, and saves you time.
Below are just a few examples of the exciting savings you'll experience during this year's Sale:
Cognitex is formulated to take advantage of the latest developments and ingredients for cognitive health. The latest ingredient in the Cognitex formula is uridine-5’-monophosphate, a critical brain nutrient.
Uridine-5’-monophosphate (UMP) is a basic building block of RNA and DNA as well as of phosphatides such as phosphatidylcholine that are critical to optimal brain function and the health of neuronal cell membranes. Naturally found in the milk of nursing mothers, UMP is essential not only for the growth and development of infant brains, but also for healthy cognitive function in aging adults.
The Cognitex formula provides other critical extracts that support healthy brain function, such as blueberry standardized with both anthocyanins and pterostilbene.
Quercetin is a bioflavonoid that supports cellular health and function. In human cell culture studies, it has been shown to block the manufacture and release of inflammation-causing substances, which can help support a healthy immune response to the seasonally changing environment. It also helps promote a healthy cardiovascular system by preserving endothelial integrity and supporting healthy blood glucose levels for those already within normal range. Optimized Quercetin is a proprietary formulation that sets the “gold standard” for high-quality quercetin derived from a food-source blend.